NEW YORK (GenomeWeb) – Taconic Biosciences has signed a license agreement with ERS Genomics to use ERS' CRISPR-Cas9 technology to generate unique murine models.

Under the agreement, Taconic receives a worldwide, non-exclusive license to CRISPR-Cas9 intellectual property often referred to as the UC Berkeley patent. ERS founder Emmanuelle Charpentier is a co-inventor of the technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.